2008

Correction of Retardation and Autism in Mice Points to Human Treatment

Researchers at MIT’s Picower Institute for Learning and Memory have corrected key symptoms of mental retardation and autism in mice. Their findings indicate that a certain class of drugs could have the same effect in humans.

Fragile X syndrome (FXS), affecting 100,000 Americans, is the most common inherited cause of mental retardation and autism. The MIT researchers corrected FXS in mice modeling the disease. The findings support the theory that many of FXS’s psychiatric and neurological symptoms such as learning disabilities, autistic behavior, and childhood epilepsy, stem from too much activation of one of the brain’s chief network managers, the metabotropic glutamate receptor mGluR5. By reducing mGluR5, the excesses can be reduced.

Individuals with FXS have mutations in the X chromosome’s FMR1 gene, which encodes the fragile X mental retardation protein, FMRP. The MIT study found that FMRP and mGluR5 keep each other in check and, without FMRP, mGluR5 signals run rampant.

Find out more here.

White Papers

3D Printing with FDM: How it Works
Sponsored by Stratasys
Design & Electrical Function of the CM1000S28
Sponsored by abbott
Back to Basics of Electrical Measurement
Sponsored by Keithley
Spectrum Analyzer Fundamentals - Theory and Operation of Modern Spectrum Analyzers
Sponsored by Rohde and Schwarz A and D
An Alternative to Check Fixtures
Sponsored by Faro
Measurement of Harmonics using Spectrum Analyzers
Sponsored by Rohde and Schwarz A and D

White Papers Sponsored By: